Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egberts

Showing results (901-910 of 1,066) with videos related to

Pageof 107
Sort By:
International Journal of Cancer|January 22, 2015
Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancerFreya A Goumas, Reinhild Holmer, Jan-Hendrik Egberts, et al.
Journal of Robotic Surgery|March 27, 2021
Robotic infant surgery with 3 mm instruments: a study in piglets of less than 10 kg body weightThomas F Krebs, Jan-Hendrik Egberts, Ulf Lorenzen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
A multimarker prognostic assay for primary cutaneous melanomaMohammed Kashani-Sabet, Suraj Venna, Mehdi Nosrati, et al.
Pharmaceutics|June 27, 2024
Serum Concentration-Dose Relationship and Modulation Factors in Children and Adolescents Treated with FluvoxamineRegina Taurines, Gesa Kunkel, Stefanie Fekete, et al.
Clinical Pharmacology and Therapeutics|May 29, 2020
Prediction of Drug Exposure in Critically Ill Encephalopathic Neonates Treated With Therapeutic Hypothermia Based on a Pooled Population Pharmacokinetic Analysis of Seven Drugs and Five MetabolitesLaurent M A Favié, Timo R de Haan, Yuma A Bijleveld, et al.
The Lancet. Oncology|January 27, 2009
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trialPeter Kenemans, Nigel J Bundred, Jean-Michel Foidart, et al.
Cell Death & Disease|April 20, 2018
The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cellsKaren Legler, Charlotte Hauser, Jan-Hendrik Egberts, et al.
Innate Immunity|December 17, 2013
Characteristic changes in microbial community composition and expression of innate immune genes in acute appendicitisAlexander Arlt, Richa Bharti, Imre Ilves, et al.
The Journal of Clinical Psychiatry|July 20, 2023
Therapeutic Reference Range for Olanzapine in Schizophrenia: Systematic Review on Blood Concentrations, Clinical Effects, and Dopamine Receptor OccupancyKatja Wesner, Christoph Hiemke, Niels Bergemann, et al.
Journal of Neurology|February 24, 2005
High specificity of myositis specific autoantibodies for myositis compared with other neuromuscular disordersG J D Hengstman, L van Brenk, W T M Vree Egberts, et al.
Pageof 107

Showing results (901-910 of 1,066) with videos related to

Sort By:
Pageof 107
International Journal of Cancer|January 22, 2015
Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancerFreya A Goumas, Reinhild Holmer, Jan-Hendrik Egberts, et al.
Journal of Robotic Surgery|March 27, 2021
Robotic infant surgery with 3 mm instruments: a study in piglets of less than 10 kg body weightThomas F Krebs, Jan-Hendrik Egberts, Ulf Lorenzen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
A multimarker prognostic assay for primary cutaneous melanomaMohammed Kashani-Sabet, Suraj Venna, Mehdi Nosrati, et al.
Pharmaceutics|June 27, 2024
Serum Concentration-Dose Relationship and Modulation Factors in Children and Adolescents Treated with FluvoxamineRegina Taurines, Gesa Kunkel, Stefanie Fekete, et al.
Clinical Pharmacology and Therapeutics|May 29, 2020
Prediction of Drug Exposure in Critically Ill Encephalopathic Neonates Treated With Therapeutic Hypothermia Based on a Pooled Population Pharmacokinetic Analysis of Seven Drugs and Five MetabolitesLaurent M A Favié, Timo R de Haan, Yuma A Bijleveld, et al.
The Lancet. Oncology|January 27, 2009
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trialPeter Kenemans, Nigel J Bundred, Jean-Michel Foidart, et al.
Cell Death & Disease|April 20, 2018
The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cellsKaren Legler, Charlotte Hauser, Jan-Hendrik Egberts, et al.
Innate Immunity|December 17, 2013
Characteristic changes in microbial community composition and expression of innate immune genes in acute appendicitisAlexander Arlt, Richa Bharti, Imre Ilves, et al.
The Journal of Clinical Psychiatry|July 20, 2023
Therapeutic Reference Range for Olanzapine in Schizophrenia: Systematic Review on Blood Concentrations, Clinical Effects, and Dopamine Receptor OccupancyKatja Wesner, Christoph Hiemke, Niels Bergemann, et al.
Journal of Neurology|February 24, 2005
High specificity of myositis specific autoantibodies for myositis compared with other neuromuscular disordersG J D Hengstman, L van Brenk, W T M Vree Egberts, et al.
Pageof 107